IWC
RADX

Integrated Wealth Concepts’s Radiopharm Theranostics RADX Stock Holding History

Integrated Wealth Concepts’s Portfolio RADX Stock Details RADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49K Buy
+1,310
New +$5.83K ﹤0.01% 4924

Other funds holding RADX

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.81B AUM 52.11% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Integrated Wealth Concepts's RADX Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Radiopharm Theranostics (RADX) in Q2 2026: 1,310 shares worth $5.49K. The stake represents ﹤0.01% of the portfolio and ranks #4924 among its holdings.

7 funds tracked by Wall St. Rank hold RADX as of Q2 2026.

  • Integrated Wealth Concepts held 1,310 shares of Radiopharm Theranostics worth $5.49K as of Q2 2026.
  • Radiopharm Theranostics was a new Integrated Wealth Concepts position in Q2 2026.
  • Radiopharm Theranostics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4924 holding.
  • 7 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.